Dr Ana-Mishel (AM) Spiroski and Ziad Mallat
Dec 18, 2025, 23:22
Dr Ana-Mishel (AM) Spiroski Shares Ziad Mallat’s Article: Translating Nobel Prize-Winning Treg Cell Science Into Cardiovascular Therapy
Dr Ana-Mishel (AM) Spiroski, Cardiovascular TA Lead, Age-Related Diseases TA Lead, Group Leader, In Vivo Pharmacology at Evotec, quoted Ziad Mallat’s post on LinkedIn:
“This is one of the most exciting areas in cardiovascular drug development. A fantastic comment by Professor Zallat Cambridge Cardiovascular on the potential of immune tolerance in cardiovascular therapeutics.”
Quoting Ziad Mallat’s post:
“Here’s the full PDF of the comment published in Nature Cardiovascular Reserach. Translating Nobel Prize-winning Treg cell science into cardiovascular therapy.”
Read full article here.
Follow the latest in Hemostasis Today.
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly
-
May 27, 2026, 15:59Sara Trompeter: Improving Transfusion Safety Through Advanced Blood Matching in SCD
-
May 27, 2026, 15:58Hassan Raza: Global Advocacy for People With Bleeding Disorders Must Continue Beyond Adoption
-
May 27, 2026, 15:43Aryabhatta Sadhu: Effective Hemotherapy Beyond Transfusion
-
May 27, 2026, 15:38Wolfgang Miesbach: How Haemophilia Care Has Evolved in China
-
May 27, 2026, 15:27Saja Abo Thyab: How MDS Can Progress to AML